CA Stock MarketDetailed Quotes
PCRX PharmaCorp Rx Inc
- 0.520
- -0.020-3.70%
15min DelayMarket Closed Dec 24 13:00 ET
60.12MMarket Cap-20.00P/E (TTM)
0.520High0.520Low10.00KVolume0.520Open0.540Pre Close5.20KTurnover0.87552wk High0.01%Turnover Ratio115.62MShares0.43052wk Low-0.026EPS TTM52.83MFloat Cap0.875Historical HighLossP/E (Static)101.60MShs Float0.430Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM2.02P/B1Lot Size--Div YieldTTM
PharmaCorp Rx Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -77.92%-157.39K | -217.57%-189.3K | -332.22%-519.46K | -5,182.63%-289.96K | -679.91%-81.42K | -351.04%-88.46K | 37.80%-59.61K | -120.18K | 5.71K | -10.44K |
| Net income from continuing operations | -759.63%-594.08K | -140.28%-202.47K | 9.02%-470.43K | -8,256.90%-216.19K | -589.94%-100.86K | 84.53%-69.11K | 4.62%-84.26K | ---517.09K | ---2.59K | --20.59K |
| Remuneration paid in stock | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --386.28K | --0 | --0 |
| Change In working capital | 2,227.81%411.82K | -46.59%13.17K | -561.59%-49.03K | -989.66%-73.77K | 162.66%19.44K | -147.38%-19.35K | 429.04%24.66K | --10.62K | --8.29K | ---31.03K |
| -Change in prepaid assets | --15.79K | ---998 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 1,117.88%197K | -42.54%14.17K | 400.87%29.72K | -39.95%4.98K | 162.66%19.44K | -195.11%-19.35K | 429.04%24.66K | ---9.88K | --8.29K | ---31.03K |
| -Change in other working capital | ---- | ---- | -484.15%-78.75K | ---- | ---- | ---- | ---- | --20.5K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -77.92%-157.39K | -217.57%-189.3K | -332.22%-519.46K | -5,182.63%-289.96K | -679.91%-81.42K | -351.04%-88.46K | 37.80%-59.61K | ---120.18K | --5.71K | ---10.44K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 252,964.26%19.84M | 0 | -98.51%27.84K | 0 | 0 | -99.58%7.84K | 20K | 1.87M | 0 | 0 |
| Net common stock issuance | 251,076.81%19.69M | --0 | -98.61%27.84K | --0 | --0 | -99.61%7.84K | --20K | --2M | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---126.46K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 252,964.26%19.84M | --0 | -98.51%27.84K | --0 | --0 | -99.58%7.84K | --20K | --1.87M | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -23.81%2.05M | -17.99%2.24M | 178.91%2.73M | -7.18%2.53M | -4.56%2.61M | 204.66%2.69M | 178.91%2.73M | --980.03K | --2.73M | --2.74M |
| Current changes in cash | 24,604.68%19.76M | -377.92%-189.3K | -128.04%-491.62K | -5,182.63%-289.96K | -679.91%-81.42K | -104.35%-80.62K | 58.67%-39.61K | --1.75M | --5.71K | ---10.44K |
| End cash Position | 734.57%21.81M | -23.81%2.05M | -17.99%2.24M | -17.99%2.24M | -7.18%2.53M | -4.56%2.61M | 204.66%2.69M | --2.73M | --2.73M | --2.73M |
| Free cash from | -85.71%-164.28K | -217.57%-189.3K | -332.22%-519.46K | -5,182.63%-289.96K | -679.91%-81.42K | -351.04%-88.46K | 37.80%-59.61K | ---120.18K | --5.71K | ---10.44K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data